Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1979 1
1991 4
1992 3
1995 2
1996 1
1997 1
2000 2
2001 2
2002 6
2003 6
2004 8
2005 2
2006 2
2007 3
2008 2
2009 3
2010 2
2011 3
2012 3
2013 3
2014 5
2015 2
2016 2
2017 7
2018 3
2019 1
2020 6
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Results by year
Filters applied: . Clear all
Page 1
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01).
Balana C, Vaz MA, Manuel Sepúlveda J, Mesia C, Del Barco S, Pineda E, Muñoz-Langa J, Estival A, de Las Peñas R, Fuster J, Gironés R, Navarro LM, Gil-Gil M, Alonso M, Herrero A, Peralta S, Olier C, Perez-Segura P, Covela M, Martinez-García M, Berrocal A, Gallego O, Luque R, Perez-Martín FJ, Esteve A, Munne N, Domenech M, Villa S, Sanz C, Carrato C. Balana C, et al. Among authors: gallego o. Neuro Oncol. 2020 Dec 18;22(12):1851-1861. doi: 10.1093/neuonc/noaa107. Neuro Oncol. 2020. PMID: 32328662 Free PMC article. Clinical Trial.
Pseudoprogression as an adverse event of glioblastoma therapy.
Balaña C, Capellades J, Pineda E, Estival A, Puig J, Domenech S, Verger E, Pujol T, Martinez-García M, Oleaga L, Velarde J, Mesia C, Fuentes R, Marruecos J, Del Barco S, Villà S, Carrato C, Gallego O, Gil-Gil M, Craven-Bartle J, Alameda F; GLIOCAT Group. Balaña C, et al. Among authors: gallego o. Cancer Med. 2017 Dec;6(12):2858-2866. doi: 10.1002/cam4.1242. Epub 2017 Nov 3. Cancer Med. 2017. PMID: 29105360 Free PMC article.
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma.
Esteve-Codina A, Alameda F, Carrato C, Pineda E, Arpí O, Martinez-García M, Mallo M, Gut M, Dabad M, Tortosa A, Del Barco S, Capellades J, Puig J, Gallego O, Pujol T, Oleaga L, Gil-Gil M, de Quintana-Schmidt C, Valduvieco I, Martinez-Cardús A, Bellosillo B, Muñoz-Marmol AM, Esteve A, Domenech M, Camins A, Craven-Bartle J, Villa S, Marruecos J, Domenech S, de la Iglesia N, Balana C. Esteve-Codina A, et al. Among authors: gallego o. Clin Cancer Res. 2021 Jan 15;27(2):645-655. doi: 10.1158/1078-0432.CCR-20-2141. Epub 2020 Oct 26. Clin Cancer Res. 2021. PMID: 33106291
Organ preservation in patients with advanced laryngeal tumours. Results of induction chemotherapy versus chemoradiotherapy in actual clinical practice.
León X, Montoro V, García J, López M, Farré N, Majercakova K, Gallego Ó, López-Pousa A, Quer M. León X, et al. Among authors: gallego o. Acta Otorrinolaringol Esp (Engl Ed). 2021 May-Jun;72(3):143-151. doi: 10.1016/j.otorri.2020.02.007. Epub 2020 May 29. Acta Otorrinolaringol Esp (Engl Ed). 2021. PMID: 32475610 English, Spanish.
Organ preservation after treatment with induction chemotherapy in patients with locally advanced carcinomas (T3-T4) of oral cavity and oropharynx.
León X, García J, López M, Farré N, Majercakova K, Gallego Ó, López-Pousa A, Quer M. León X, et al. Among authors: gallego o. Acta Otorrinolaringol Esp (Engl Ed). 2021 Jan-Feb;72(1):27-36. doi: 10.1016/j.otorri.2020.01.001. Epub 2020 Jun 6. Acta Otorrinolaringol Esp (Engl Ed). 2021. PMID: 32513455 English, Spanish.
SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).
Sepúlveda-Sánchez JM, Muñoz Langa J, Arráez MÁ, Fuster J, Hernández Laín A, Reynés G, Rodríguez González V, Vicente E, Vidal Denis M, Gallego Ó. Sepúlveda-Sánchez JM, et al. Among authors: gallego o. Clin Transl Oncol. 2018 Jan;20(1):3-15. doi: 10.1007/s12094-017-1790-3. Epub 2017 Nov 9. Clin Transl Oncol. 2018. PMID: 29124520 Free PMC article.
80 results